{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:26:29Z","timestamp":1791354389696,"version":"4.3.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"crossref","award":["D15D18000410001"],"award-info":[{"award-number":["D15D18000410001"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-026-02058-x","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:44:58Z","timestamp":1771551898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A proteomics approach to identify predictive blood biomarkers for pleural mesothelioma in prospective cohorts"],"prefix":"10.1007","volume":"26","author":[{"given":"Elton Jalis","family":"Herman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Allione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Viberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadija","family":"Sana-Hafeez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Johnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Br\u00fcning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Mirabelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Dianzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Agudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabete","family":"Weiderpass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Simeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Kaaks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e","family":"Turzanski-Fortner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Tumino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"G\u00e1lvez-Navas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias B.","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Schiborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Cabrera","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Masala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Vineis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Casalone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Matullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"issue":"8","key":"2058_CR1","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1200\/JCO-24-02425","volume":"43","author":"HL Kindler","year":"2025","unstructured":"Kindler HL, Ismaila N, Bazhenova L, Chu Q, Churpek JE, Dagogo-Jack I, et al. Treatment of pleural mesothelioma: ASCO guideline update. J Clin Oncol. 2025;43(8):1006\u201338.","journal-title":"J Clin Oncol"},{"issue":"9483","key":"2058_CR2","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","volume":"366","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Musk AW, Lake RA. Malignant mesothelioma. Lancet. 2005;366(9483):397\u2013408.","journal-title":"Lancet"},{"issue":"13","key":"2058_CR3","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMra1912719","volume":"385","author":"SM Janes","year":"2021","unstructured":"Janes SM, Alrifai D, Fennell DA. Perspectives on the treatment of malignant pleural mesothelioma. N Engl J Med. 2021;385(13):1207\u201318.","journal-title":"N Engl J Med"},{"issue":"8","key":"2058_CR4","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.jtho.2022.03.012","volume":"17","author":"S Laaksonen","year":"2022","unstructured":"Laaksonen S, Kettunen E, Sutinen E, Ilonen I, Vehmas T, Tormakangas T, et al. Pulmonary asbestos fiber burden is related to patient survival in malignant pleural mesothelioma. J Thorac Oncol. 2022;17(8):1032\u201341.","journal-title":"J Thorac Oncol"},{"issue":"12","key":"2058_CR5","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","volume":"8","author":"J Hmeljak","year":"2018","unstructured":"Hmeljak J, Sanchez-Vega F, Hoadley KA, Shih J, Stewart C, Heiman D, et al. Integrative molecular characterization of malignant pleural mesothelioma. Cancer Discov. 2018;8(12):1548\u201365.","journal-title":"Cancer Discov"},{"issue":"4","key":"2058_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng.3520","volume":"48","author":"R Bueno","year":"2016","unstructured":"Bueno R, Stawiski EW, Goldstein LD, Durinck S, De Rienzo A, Modrusan Z, et al. Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Nat Genet. 2016;48(4):407\u201316.","journal-title":"Nat Genet"},{"issue":"4","key":"2058_CR7","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41588-023-01321-1","volume":"55","author":"L Mangiante","year":"2023","unstructured":"Mangiante L, Alcala N, Sexton-Oates A, Di Genova A, Gonzalez-Perez A, Khandekar A, et al. Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity. Nat Genet. 2023;55(4):607\u201318.","journal-title":"Nat Genet"},{"issue":"12","key":"2058_CR8","first-page":"100735","volume":"5","author":"S Schmid","year":"2024","unstructured":"Schmid S, Holer L, Gysel K, Koster KL, Rothschild SI, Boos LA, et al. Real-World outcomes of patients with malignant pleural mesothelioma receiving a combination of ipilimumab and nivolumab as First- or Later-Line treatment. JTO Clin Res Rep. 2024;5(12):100735.","journal-title":"JTO Clin Res Rep"},{"issue":"12","key":"2058_CR9","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1158\/1055-9965.EPI-20-0083","volume":"29","author":"HI Pass","year":"2020","unstructured":"Pass HI, Alimi M, Carbone M, Yang H, Goparaju CM. Mesothelioma biomarkers: A review highlighting contributions from the early detection research network. Cancer Epidemiol Biomarkers Prev. 2020;29(12):2524\u201340.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"2058_CR10","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/carcin\/bgt166","volume":"34","author":"Y Sekido","year":"2013","unstructured":"Sekido Y. Molecular pathogenesis of malignant mesothelioma. Carcinogenesis. 2013;34(7):1413\u20139.","journal-title":"Carcinogenesis"},{"issue":"4","key":"2058_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrc1043","volume":"3","author":"JD Wulfkuhle","year":"2003","unstructured":"Wulfkuhle JD, Liotta LA, Petricoin EF. Proteomic applications for the early detection of cancer. Nat Rev Cancer. 2003;3(4):267\u201375.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"2058_CR12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/PPO.0b013e3182383cab","volume":"17","author":"S Hanash","year":"2011","unstructured":"Hanash S, Taguchi A. Application of proteomics to cancer early detection. Cancer J. 2011;17(6):423\u20138.","journal-title":"Cancer J"},{"issue":"4","key":"2058_CR13","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/ijc.34339","volume":"152","author":"A Allione","year":"2023","unstructured":"Allione A, Viberti C, Cotellessa I, Catalano C, Casalone E, Cugliari G, et al. Blood cell DNA methylation biomarkers in preclinical malignant pleural mesothelioma: the EPIC prospective cohort. Int J Cancer. 2023;152(4):725\u201337.","journal-title":"Int J Cancer"},{"issue":"10","key":"2058_CR14","doi-asserted-by":"publisher","first-page":"e46091","DOI":"10.1371\/journal.pone.0046091","volume":"7","author":"RM Ostroff","year":"2012","unstructured":"Ostroff RM, Mehan MR, Stewart A, Ayers D, Brody EN, Williams SA, et al. Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool. PLoS ONE. 2012;7(10):e46091.","journal-title":"PLoS ONE"},{"issue":"5","key":"2058_CR15","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.bbapap.2013.12.007","volume":"1844","author":"B Pesch","year":"2014","unstructured":"Pesch B, Bruning T, Johnen G, Casjens S, Bonberg N, Taeger D, et al. Biomarker research with prospective study designs for the early detection of cancer. Biochim Biophys Acta. 2014;1844(5):874\u201383.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"2058_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41576-020-0268-2","volume":"22","author":"K Suhre","year":"2021","unstructured":"Suhre K, McCarthy MI, Schwenk JM. Genetics Meets proteomics: perspectives for large population-based studies. Nat Rev Genet. 2021;22(1):19\u201337.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"2058_CR17","doi-asserted-by":"publisher","first-page":"4308","DOI":"10.1038\/s41467-023-39765-y","volume":"14","author":"MB Alvez","year":"2023","unstructured":"Alvez MB, Edfors F, von Feilitzen K, Zwahlen M, Mardinoglu A, Edqvist PH, et al. Next generation pan-cancer blood proteome profiling using proximity extension assay. Nat Commun. 2023;14(1):4308.","journal-title":"Nat Commun"},{"issue":"6B","key":"2058_CR18","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1079\/PHN2002394","volume":"5","author":"E Riboli","year":"2002","unstructured":"Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European prospective investigation into cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002;5(6B):1113\u201324.","journal-title":"Public Health Nutr"},{"issue":"Suppl 1","key":"2058_CR19","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1093\/ije\/26.suppl_1.S6","volume":"26","author":"E Riboli","year":"1997","unstructured":"Riboli E, Kaaks R. The EPIC project: rationale and study design. European prospective investigation into cancer and nutrition. Int J Epidemiol. 1997;26(Suppl 1):S6\u201314.","journal-title":"Int J Epidemiol"},{"key":"2058_CR20","doi-asserted-by":"crossref","unstructured":"Weber DG, Casjens S, Wichert K, Lehnert M, Taeger D, Rihs HP et al. Tasks and experiences of the Prospective, Longitudinal, multicenter MoMar (Molecular Markers) study for the early detection of mesothelioma in individuals formerly exposed to asbestos using liquid biopsies. Cancers (Basel). 2023;15(24):5896.","DOI":"10.3390\/cancers15245896"},{"issue":"8","key":"2058_CR21","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/ajim.23401","volume":"65","author":"D Taeger","year":"2022","unstructured":"Taeger D, Wichert K, Lehnert M, Casjens S, Pesch B, Weber DG, et al. Lung cancer and mesothelioma risks in a prospective cohort of workers with asbestos-related lung or pleural diseases. Am J Ind Med. 2022;65(8):652\u20139.","journal-title":"Am J Ind Med"},{"key":"2058_CR22","doi-asserted-by":"crossref","unstructured":"Casalone E, Birolo G, Pardini B, Allione A, Russo A, Catalano C et al. Serum extracellular Vesicle-Derived MicroRNAs as potential biomarkers for pleural mesothelioma in a European prospective study. Cancers (Basel). 2022;15(1):125.","DOI":"10.3390\/cancers15010125"},{"key":"2058_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jprot.2018.10.017","volume":"195","author":"M Manfredi","year":"2019","unstructured":"Manfredi M, Conte E, Barberis E, Buzzi A, Robotti E, Caneparo V, et al. Integrated serum proteins and fatty acids analysis for putative biomarker discovery in inflammatory bowel disease. J Proteom. 2019;195:138\u201349.","journal-title":"J Proteom"},{"issue":"11","key":"2058_CR24","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1002\/jcb.25549","volume":"117","author":"S Martinotti","year":"2016","unstructured":"Martinotti S, Patrone M, Manfredi M, Gosetti F, Pedrazzi M, Marengo E, et al. HMGB1 Osteo-Modulatory action on osteosarcoma SaOS-2 cell line: an integrated study from biochemical and -Omics approaches. J Cell Biochem. 2016;117(11):2559\u201369.","journal-title":"J Cell Biochem"},{"issue":"5","key":"2058_CR25","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"2","key":"2058_CR26","doi-asserted-by":"publisher","first-page":"e039079","DOI":"10.1136\/bmjopen-2020-039079","volume":"11","author":"S Casjens","year":"2021","unstructured":"Casjens S, Johnen G, Raiko I, Pesch B, Taeger D, Topfer C, et al. Re-evaluation of potential predictors of calretinin and mesothelin in a population-based cohort study using assays for the routine application in clinical medicine. BMJ Open. 2021;11(2):e039079.","journal-title":"BMJ Open"},{"key":"2058_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.canlet.2021.06.008","volume":"517","author":"H Wang","year":"2021","unstructured":"Wang H, Liu B, Wei J. Beta2-microglobulin(B2M) in cancer immunotherapies: biological function, resistance and remedy. Cancer Lett. 2021;517:96\u2013104.","journal-title":"Cancer Lett"},{"issue":"12","key":"2058_CR28","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41568-019-0210-0","volume":"19","author":"LT Roumenina","year":"2019","unstructured":"Roumenina LT, Daugan MV, Petitprez F, Sautes-Fridman C, Fridman WH. Context-dependent roles of complement in cancer. Nat Rev Cancer. 2019;19(12):698\u2013715.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2058_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/sj.bjc.6604458","volume":"99","author":"GD Stewart","year":"2008","unstructured":"Stewart GD, Skipworth RJ, Pennington CJ, Lowrie AG, Deans DA, Edwards DR, et al. Variation in Dermcidin expression in a range of primary human tumours and in hypoxic\/oxidatively stressed human cell lines. Br J Cancer. 2008;99(1):126\u201332.","journal-title":"Br J Cancer"},{"issue":"1","key":"2058_CR30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41420-021-00550-9","volume":"7","author":"J Zhao","year":"2021","unstructured":"Zhao J, Peng H, Gao J, Nong A, Hua H, Yang S, et al. Current insights into the expression and functions of tumor-derived Immunoglobulins. Cell Death Discov. 2021;7(1):148.","journal-title":"Cell Death Discov"},{"issue":"1","key":"2058_CR31","doi-asserted-by":"publisher","first-page":"14321","DOI":"10.1038\/s41598-018-32315-3","volume":"8","author":"G Johnen","year":"2018","unstructured":"Johnen G, Burek K, Raiko I, Wichert K, Pesch B, Weber DG, et al. Prediagnostic detection of mesothelioma by Circulating calretinin and mesothelin - a case-control comparison nested into a prospective cohort of asbestos-exposed workers. Sci Rep. 2018;8(1):14321.","journal-title":"Sci Rep"},{"issue":"1","key":"2058_CR32","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1186\/s40001-025-03003-6","volume":"30","author":"S Zafar","year":"2025","unstructured":"Zafar S, Hafeez A, Shah H, Mutiullah I, Ali A, Khan K, et al. Emerging biomarkers for early cancer detection and diagnosis: challenges, innovations, and clinical perspectives. Eur J Med Res. 2025;30(1):760.","journal-title":"Eur J Med Res"},{"issue":"4","key":"2058_CR33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1158\/1055-9965.EPI-15-0849","volume":"25","author":"AE Prizment","year":"2016","unstructured":"Prizment AE, Linabery AM, Lutsey PL, Selvin E, Nelson HH, Folsom AR, et al. Circulating Beta-2 microglobulin and risk of cancer: the atherosclerosis risk in communities study (ARIC). Cancer Epidemiol Biomarkers Prev. 2016;25(4):657\u201364.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6286","key":"2058_CR34","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/346751a0","volume":"346","author":"B Perarnau","year":"1990","unstructured":"Perarnau B, Siegrist CA, Gillet A, Vincent C, Kimura S, Lemonnier FA. Beta 2-microglobulin restriction of antigen presentation. Nature. 1990;346(6286):751\u20134.","journal-title":"Nature"},{"issue":"4","key":"2058_CR35","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.4049\/jimmunol.174.4.2116","volume":"174","author":"D Berko","year":"2005","unstructured":"Berko D, Carmi Y, Cafri G, Ben-Zaken S, Sheikhet HM, Tzehoval E, et al. Membrane-anchored beta 2-microglobulin stabilizes a highly receptive state of MHC class I molecules. J Immunol. 2005;174(4):2116\u201323.","journal-title":"J Immunol"},{"key":"2058_CR36","doi-asserted-by":"publisher","first-page":"636568","DOI":"10.3389\/fimmu.2021.636568","volume":"12","author":"K Dhatchinamoorthy","year":"2021","unstructured":"Dhatchinamoorthy K, Colbert JD, Rock KL. Cancer immune evasion through loss of MHC class I antigen presentation. Front Immunol. 2021;12:636568.","journal-title":"Front Immunol"},{"issue":"4","key":"2058_CR37","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00262-022-03292-4","volume":"72","author":"R Okita","year":"2023","unstructured":"Okita R, Mimura-Kimura Y, Kawamoto N, Yamamoto N, Umeda M, Okada M, et al. Effects of tumor-infiltrating CD8\u2009+\u2009T cells, PD1\/PD-L1 axis, and expression patterns of HLA class I on the prognosis of patients with malignant pleural mesothelioma who underwent extra-pleural pneumonectomy. Cancer Immunol Immunother. 2023;72(4):865\u201379.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"2058_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1179\/1351000213Y.0000000075","volume":"19","author":"S Toyokuni","year":"2014","unstructured":"Toyokuni S. Iron overload as a major targetable pathogenesis of asbestos-induced mesothelial carcinogenesis. Redox Rep. 2014;19(1):1\u20137.","journal-title":"Redox Rep"},{"issue":"3","key":"2058_CR39","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/path.4075","volume":"228","author":"L Jiang","year":"2012","unstructured":"Jiang L, Akatsuka S, Nagai H, Chew SH, Ohara H, Okazaki Y, et al. Iron overload signature in chrysotile-induced malignant mesothelioma. J Pathol. 2012;228(3):366\u201377.","journal-title":"J Pathol"},{"key":"2058_CR40","doi-asserted-by":"publisher","unstructured":"Klikovits T et al. Nov. Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma. Scientific reports vol. 7,1 16456. 28 2017, https:\/\/doi.org\/10.1038\/s41598-017-16551-7","DOI":"10.1038\/s41598-017-16551-7"},{"key":"2058_CR41","doi-asserted-by":"publisher","unstructured":"Agostinis C et al. Nov. Complement Protein C1q Binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumor Growth. Frontiers in immunology vol. 8 1559. 20 2017, https:\/\/doi.org\/10.3389\/fimmu.2017.01559","DOI":"10.3389\/fimmu.2017.01559"},{"key":"2058_CR42","doi-asserted-by":"crossref","unstructured":"Rouka E, Beltsios E, Goundaroulis D, Vavougios GD, Solenov EI, Hatzoglou C et al. In Silico transcriptomic analysis of Wound-Healing-Associated genes in malignant pleural mesothelioma. Med (Kaunas). 2019;55(6):267.","DOI":"10.3390\/medicina55060267"},{"key":"2058_CR43","doi-asserted-by":"crossref","unstructured":"Harber J, Kamata T, Pritchard C, Fennell D. Matter of TIME: the tumor-immune microenvironment of mesothelioma and implications for checkpoint Blockade efficacy. J Immunother Cancer. 2021;9(9):e003032.","DOI":"10.1136\/jitc-2021-003032"},{"issue":"3","key":"2058_CR44","doi-asserted-by":"publisher","first-page":"152817","DOI":"10.1016\/j.prp.2020.152817","volume":"216","author":"M Matsuda","year":"2020","unstructured":"Matsuda M, Ninomiya H, Wakejima R, Inamura K, Okumura S, Mun M, et al. Calretinin-expressing lung adenocarcinoma: distinct characteristics of advanced stages, smoker-type features, and rare expression of other mesothelial markers are useful to differentiate epithelioid mesothelioma. Pathol Res Pract. 2020;216(3):152817.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"2058_CR45","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s13104-020-05187-y","volume":"13","author":"M Lehnert","year":"2020","unstructured":"Lehnert M, Weber DG, Taeger D, Raiko I, Kollmeier J, Stephan-Falkenau S, et al. Determinants of plasma calretinin in patients with malignant pleural mesothelioma. BMC Res Notes. 2020;13(1):359.","journal-title":"BMC Res Notes"},{"issue":"1","key":"2058_CR46","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1186\/s12885-017-3375-5","volume":"17","author":"G Johnen","year":"2017","unstructured":"Johnen G, Gawrych K, Raiko I, Casjens S, Pesch B, Weber DG, et al. Calretinin as a blood-based biomarker for mesothelioma. BMC Cancer. 2017;17(1):386.","journal-title":"BMC Cancer"},{"key":"2058_CR47","doi-asserted-by":"crossref","unstructured":"Zupanc C, Franko A, Strbac D, Dodic Fikfak M, Kovac V, Dolzan V et al. Serum calretinin as a biomarker in malignant mesothelioma. J Clin Med. 2021;10(21):4875.","DOI":"10.3390\/jcm10214875"},{"issue":"10","key":"2058_CR48","doi-asserted-by":"publisher","first-page":"e017104","DOI":"10.1136\/bmjopen-2017-017104","volume":"7","author":"S Casjens","year":"2017","unstructured":"Casjens S, Weber DG, Johnen G, Raiko I, Taeger D, Meinig C, et al. Assessment of potential predictors of calretinin and mesothelin to improve the diagnostic performance to detect malignant mesothelioma: results from a population-based cohort study. BMJ Open. 2017;7(10):e017104.","journal-title":"BMJ Open"},{"issue":"9","key":"2058_CR49","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1158\/1055-9965.EPI-10-0346","volume":"19","author":"J Creaney","year":"2010","unstructured":"Creaney J, Olsen NJ, Brims F, Dick IM, Musk AW, de Klerk NH, et al. Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma. Cancer Epidemiol Biomarkers Prev. 2010;19(9):2238\u201346.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2058_CR50","unstructured":"Extended screening program for the early detection of occupational mesothelioma (EVA-Mesothel). https:\/\/www.dguv.de\/ipa\/eva-mesothel\/index-2.jsp. (Accessed 21 October 2025)."},{"issue":"1\u20132","key":"2058_CR51","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/prca.201300074","volume":"8","author":"S Ray","year":"2014","unstructured":"Ray S, Patel SK, Kumar V, Damahe J, Srivastava S. Differential expression of serum\/plasma proteins in various infectious diseases: specific or nonspecific signatures. Proteom Clin Appl. 2014;8(1\u20132):53\u201372.","journal-title":"Proteom Clin Appl"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-026-02058-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02058-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-026-02058-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:01:41Z","timestamp":1783659701000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-026-02058-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2058"],"URL":"https:\/\/doi.org\/10.1007\/s10238-026-02058-x","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA) has supplied DLD Diagnostika GmbH with the antibodies to produce the Calretinin ELISA kits. In turn, the IPA has received Calretinin ELISA kits at a reduced price and may benefit from future sales of the kits. Otherwise, the individual authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Institutional Review Board of IARC and the ethics committees in the participating countries. All participants gave their written informed consent to participate in the EPIC study. The present study was carried out in accordance with the ethical principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"161"}}